Spinal zaps may reboot arm movement after paralysis or stroke

NCT ID NCT06596369

Recruiting now Disease control Sponsor: University of Alberta Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This pilot study is testing whether a noninvasive device that sends mild electrical pulses through the skin to the spinal cord can help improve arm and hand function in people with stroke or spinal cord injury. Researchers will measure changes in nerve activity and movement skills in 30 participants over several months. The goal is to understand how to best use this stimulation to aid recovery.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: transcutaneous spinal cord stimulation (a device that sends mild electrical pulses through the skin to the spinal cord)
What this could lead to: If it works, this could point toward a noninvasive way to help people regain arm and hand function after stroke or spinal cord injury.
What could go wrong: This is a small pilot study with only 30 participants, so results may not apply to everyone. The stimulation is still experimental, and it is not yet known if it will lead to meaningful functional improvements.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SPINAL CORD INJURIES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

spinal cord injury stroke disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SPINAL CORD INJURIES STROKE

Contacts and locations

Locations

Glenrose Rehabilitation Hospital
RECRUITING

Edmonton, Alberta, T5G 0B7, Canada
University of Alberta
RECRUITING

Edmonton, Alberta, T6G-2E1, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.